InterValve gets 510(k) clearance for catheter

The FDA granted 510(k) clearance to InterValve to market its V8 Aortic Valvuloplasty Balloon Catheter.

The catheter is designed to be used in stand-alone balloon aortic valvuloplasty and predilation during transcatheter aortic valve replacement  procedures. In summary documents to the FDA, the company described the system as an hourglass-shaped balloon intended to allow for full dilation of stenotic aortic valve leaflets while minimizing over-dilation of the aortic annulus.

Minneapolis-based InterValve wrote that the balloon will be available in four diameter sizes, 22 mm through 28 mm, with a catheter available in working lengths of 107 cm and 113 cm compatible with a 12F or 14F introducer sheath. It is introduced through the femoral artery.

Candace Stuart, Contributor

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup